- Omega Diagnostics said its revenue fell 27% in the first half after it discontinued two loss-making businesses.

Revenue declined to £5.2m. On a like-for-like basis, it fell 7%.

Pre-tax profit was in line with expectations, the company added, without being more specific.

'Trading in the second half of this year is expected to improve over the first half and we remain confident, both in the improved outlook for the business overall and the potential to realise value for shareholders over the shorter term,' Omega said.

At 2:37pm: [LON:ODX] Omega Diagnostics Group PLC share price was -0.35p at 15.25p

Story provided by